Clinical Trials Patient Summaries
Prostate cancer clinical trials descriptions written in formats that are easily understood by patients. Includes information identifying the locations and contacts for each trial.
MEVPRO-2 Patient Summary – Metastatic Castration Resistant
Background Information: Prostate cancer, one of the most common types of cancer, becomes metastatic when it spreads to other parts of the...
MEVPRO-1 Patient Summary – Metastatic Castration Resistant
Background Information: Prostate cancer, one of the most common types of cancer, becomes metastatic when it spreads to other parts of the body....
Omaha-003 Patient Summary – Metastatic Castration Resistant
This clinical trial is for participants who have metastatic castration-resistant prostate cancer (mCRPC) and failed to respond to drugs or surgery...
Libertas Patient Summary – Metastatic Castration Sensitive
The LIBERTAS STUDY is researching a way to potentially treat a type of prostate cancer that still responds to hormone therapy. Prostate cancer that...
Lorikeet Patient Summary – Metastatic Castration Resistant
Background Information: Our immune system protects us from disease by killing bacteria and viruses. It also helps fight cancer. A T-cell is one type...
Omaha-004 Patient Summary – Metastatic Castration Resistant
This clinical trial is for participants who have metastatic castration-resistant prostate cancer (mCRPC) and whose cancer progressed on or after...
AMG 509 Patient Summary – Metastatic Castration Resistant
This clinical trial is for patients who have metastatic castration resistant prostate cancer (mCRPC) and failed to respond to abiraterone acetate or...
MK-5684-01A Patient Summary – Metastatic Castration Resistant
Background Information Metastatic castration-resistant prostate cancer (mCRPC) is a form of prostate cancer that keeps growing even when male...
Find Your Trial
All Diagnoses
Low Risk
Intermediate Risk
High Risk
Cancer Recurrence
Non-Metastatic Castration Resistant
Metastatic Castration Sensitive
Metastatic Castration Resistant
Neuroendocrine
This information is for educational purposes only and not intended as medical advice.
Patients should consult their medical doctor for advice and recommendations about specific clinical trials.